As an oncogene, growing evidence has identified EZH2 was closely related to breast cancer development and progression through multiple molecular mechanisms35,36, but no studies are related to the roles of CENPL, ISG20L2, MRPL3 and LSM4 in breast cancer. This evidence concerns the gene LSM4 and breast cancer.